Carrier mediated action of platinum complexes on estrogen receptor positive tumors
- 1 February 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (2) , 293-299
- https://doi.org/10.1016/0277-5379(89)90022-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Platinum complexes with binding affinity for the estrogen receptorJournal of Medicinal Chemistry, 1988
- Strategies for breast cancer therapy with antiestrogensJournal of Steroid Biochemistry, 1987
- Estrogen and oncogene mediated growth regulation of human breast cancer cellsJournal of Steroid Biochemistry, 1987
- Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting propertiesJournal of Medicinal Chemistry, 1985
- Aromatase inhibition and its pharmacologic implicationsBiochemical Pharmacology, 1985
- The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumorsEuropean Journal of Cancer and Clinical Oncology, 1985
- CisplatinAnnals of Internal Medicine, 1984
- Antiestrogenic Effects of LY 117018 in MCF-7 CellsEndocrinology, 1983
- The problem of nonresponding estrogen receptor-positive patients with advanced breast cancerCancer, 1980
- Influence of Oxygen and Culture Media on Plating Efficiency of Some Mammalian Tissue CellsJNCI Journal of the National Cancer Institute, 1972